Revenue: -1.8m
$0.0/sec
#ASX:IMU Why Arafura Rare Earths, Imugene, Pilbara Minerals, and Worley ... - The Motley Fool Australia
#ASX:IMU Up 6%, guess which ASX 200 stock is the best performing so far today - The Motley Fool Australia
#ASX:IMU Cancer Vaccine Market Research - Global Opportunity Analysis and ... - Business Wire
#ASX:IMU Advanced Gastric Carcinoma Pipeline 2023 | Key Companies ... - Digital Journal
#ASX:IMU Imugene's onCARlytics and Artemis® T cells combination presented ... - Proactive Investors Australia
#ASX:IMU Imugene nets A$12.6 million research and development tax refund - Proactive Investors USA
#ASX:IMU Imugene (ASX:IMU) receives FDA IND clearance for onCARlytics ... - Kalkine Media